Table 1 Tryptase and MITF are... | American Society of Hematology

Table 1

Tryptase and MITF are coexpressed in patients with systemic mastocytosis and c-KIT mutations

Patient no.	Diagnosis		Staining
Patient no.	Diagnosis		Tryptase	MITF
1	Indolent systemic mastocytosis	D816V	++	+
2	Indolent systemic mastocytosis	D816V	++	+
3	Indolent systemic mastocytosis	D816V	++	+
4	Indolent systemic mastocytosis	D816V	++	+
5	Indolent systemic mastocytosis	D816V	++	+
6	Indolent systemic mastocytosis	D816V	++	+
7	Indolent systemic mastocytosis	D816V	++	+
8	Indolent systemic mastocytosis	D816V	++	+
9	Systemic mastocytosis	F522C	++	+
10	Aggressive systemic mastocytosis	D816Y	++	−
11	Aplastic anemia	NT	++	−
12	Aplastic anemia	NT	++	−
13	Aplastic anemia	NT	++	−
14	Aplastic anemia	NT	++	−
15	Aplastic anemia	NT	++	−
16	Aplastic anemia	NT	++	−
17	Aplastic anemia	NT	++	−
18	Fanconi anemia	NT	++	−
19	Acute lymphoblastic leukemia	NT	++	−
20	Hemophagocytic lymphohistiocytosis	NT	++	−

Patient no.	Diagnosis		Staining
Patient no.	Diagnosis		Tryptase	MITF
1	Indolent systemic mastocytosis	D816V	++	+
2	Indolent systemic mastocytosis	D816V	++	+
3	Indolent systemic mastocytosis	D816V	++	+
4	Indolent systemic mastocytosis	D816V	++	+
5	Indolent systemic mastocytosis	D816V	++	+
6	Indolent systemic mastocytosis	D816V	++	+
7	Indolent systemic mastocytosis	D816V	++	+
8	Indolent systemic mastocytosis	D816V	++	+
9	Systemic mastocytosis	F522C	++	+
10	Aggressive systemic mastocytosis	D816Y	++	−
11	Aplastic anemia	NT	++	−
12	Aplastic anemia	NT	++	−
13	Aplastic anemia	NT	++	−
14	Aplastic anemia	NT	++	−
15	Aplastic anemia	NT	++	−
16	Aplastic anemia	NT	++	−
17	Aplastic anemia	NT	++	−
18	Fanconi anemia	NT	++	−
19	Acute lymphoblastic leukemia	NT	++	−
20	Hemophagocytic lymphohistiocytosis	NT	++	−

+ indicates positive staining ++, strongly positive staining −, no detectable staining and — NT, not tested.